相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma
Wei Cao et al.
CANCER (2012)
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer
Huqun et al.
CANCER (2012)
Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis
Paul Delgado-Olguin et al.
NATURE GENETICS (2012)
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos et al.
NATURE MEDICINE (2012)
EZH2 Promotes Malignant Phenotypes and Is a Predictor of Oral Cancer Development in Patients with Oral Leukoplakia
Wei Cao et al.
CANCER PREVENTION RESEARCH (2011)
Genetic and epigenetic changes in lung carcinoma and their clinical implications
Jing Wen et al.
MODERN PATHOLOGY (2011)
Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
Francesco Crea et al.
MOLECULAR CANCER (2011)
EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/CDKN1A Expression
Tao Fan et al.
MOLECULAR CANCER RESEARCH (2011)
Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer
Jung Hye Choi et al.
APMIS (2010)
Distinctive Expression of the Polycomb Group Proteins Bmi1 Polycomb Ring Finger Oncogene and Enhancer of Zeste Homolog 2 in Nonsmall Cell Lung Cancers and Their Clinical and Clinicopathologic Significance
Junko Kikuchi et al.
CANCER (2010)
Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma
Adam D. Toll et al.
HUMAN PATHOLOGY (2010)
The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells
Ryutaro Aoki et al.
JOURNAL OF HEPATOLOGY (2010)
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
Junxia Min et al.
NATURE MEDICINE (2010)
Targeted Overexpression of EZH2 in the Mammary Gland Disrupts Ductal Morphogenesis and Causes Epithelial Hyperplasia
Xin Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
Warren Fiskus et al.
BLOOD (2009)
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
O. Fluge et al.
BRITISH JOURNAL OF CANCER (2009)
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer
Ana Belen Custodio et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma
Stefan Hinz et al.
JOURNAL OF UROLOGY (2009)
Polycomb Group Protein Enhancer of Zeste 2 Is an Oncogene That Promotes the Neoplastic Transformation of a Benign Prostatic Epithelial Cell Line
Breanne D. W. Karanikolas et al.
MOLECULAR CANCER RESEARCH (2009)
Mir-214-Dependent Regulation of the Polycomb Protein Ezh2 in Skeletal Muscle and Embryonic Stem Cells
Aster H. Juan et al.
MOLECULAR CELL (2009)
Linking DNA methylation and histone modification: patterns and paradigms
Howard Cedar et al.
NATURE REVIEWS GENETICS (2009)
Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells
Hideo Watanabe et al.
Cancer Cell International (2008)
SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus
Sima Kheradmand Kia et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma
Motoko Sasaki et al.
LABORATORY INVESTIGATION (2008)
ΔDNMT3B variants regulate DNA methylation in a promoter-specific manner
Jie Wang et al.
CANCER RESEARCH (2007)
A translational view of the molecular pathogenesis of lung cancer
Mitsuo Sato et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer
Yasuko Matsukawa et al.
CANCER SCIENCE (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer
K Collett et al.
CLINICAL CANCER RESEARCH (2006)
Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells
J Zhang et al.
CANCER RESEARCH (2006)
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
JD Raman et al.
CLINICAL CANCER RESEARCH (2005)
Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer
H Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
R Cao et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis
RHJ Breuer et al.
NEOPLASIA (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
K Vermeulen et al.
CELL PROLIFERATION (2003)
Molecular abnormalities in lung carcinogenesis and their potential clinical implications
L Mao
LUNG CANCER (2001)
Rb function in cell-cycle regulation and apoptosis
JW Harbour et al.
NATURE CELL BIOLOGY (2000)
分享论文
